Location: Home
  • search
  • go
  • Relate News
  • 12/25/2023GeneQuantum and BioMap Strikes Strategic Deal to Jointly Develop Next...
  • 12/25/2023Oncoshot Teams Up with Zhejiang Ablaze Medicine to Drive Data-Powered ...
  • 12/25/2023InxMed Enters License Agreement with Escugen to Develop Next-Generatio...
  • 12/25/2023Biocytogen Enters into Antibody Deal with Ona Therapeutics to Develop ...
  • 12/25/2023Qilu Pharma Acquires Hyperlipidemia Drug Candidate RBD7022 from Ribo...
  • 12/22/2023State Council Issues Amended Implementing Regulations of the Chinese P...
  • 12/22/2023China to Slash Import Tax on Some Anticancers and Rare Disease Drugs N...
  • 12/22/2023CDE Solicits Comments on the Dossier Requirements for Marketing Regist...
  • 12/22/2023Drug R&D and Product Registration News Digest December 2023 (3)
  • 12/21/2023Servier Acquires Rights to TIBSOVO® in Greater China and Singapore fr...
  • 12/20/2023GSK Enters Exclusive License Agreement with Hansoh for ADC HS-20093
  • 12/20/2023Huadong to Buy China Rights to Impact's Cancer Drug for $41M
  • 12/20/2023Stemirna Reportedly Behind on Employee Wages
  • 12/20/2023China NRDL 2023 Readout: the Seven-year Itch (Simon Kucher)
  • 12/19/2023GSK Is Hunting for Deals in China: FT
  • 12/19/2023China Updates Guidelines for Vaccination Practices
  • 12/19/2023CDE Issues Notice on Foreign MHA Participation in the Aging-Friendly a...
  • 12/19/2023NHC Initiates the 5th Round of Three-Year Large Hospital Inspection In...
  • 12/19/2023China Issues the Regulations on the Supervision and Law Enforcement of...
  • 12/19/2023China Makes Major Breakthrough in Inhalable Vaccine Technology
  • 12/18/2023AbelZeta Announces Amendment to Worldwide Collaboration and License Ag...
  • 12/18/2023CBMG Holdings Announces Name Change to AbelZeta Pharma, Inc.
  • 12/18/2023Pfizer/Seagen Pick Up HBM/NonaBio's ADC HBM9033 in $1B License Deal
  • 12/15/2023IQVIA: Chinese Retail Pharmacy Sales up 8.2% in MAT Q3/2023
  • 12/15/2023Drug R&D and Product Registration News Digest December 2023 (2)
  • 12/15/2023Review of Top 15 Chinese Pharma In-Licensing Deals in 2023
  • 12/15/2023LEK | Hospital Priorities in China in 2023: Strategic Implications for...
  • 12/15/2023LEK | Hospital Priorities in China in 2023: Strategic Implications for...
  • 12/15/2023Recent Official and Executive Moves
  • 12/15/2023NHC Issues Rules on Repting Medical Emergencies
  • Page:23/718 Total number of articles:21536: [First][<<] [21] [22] [23] [24] [25] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group